Home | About IPJ | Editorial board | Ahead of print | Current Issue | Archives | Instructions | Contact us |   Login 
Industrial Psychiatry Journal
Search Articles   
    
Advanced search   
 
CASE REPORT
Year : 2019  |  Volume : 28  |  Issue : 2  |  Page : 321-324

Adjunctive dexmedetomidine for treatment of delirium tremens: Case report and brief review


1 Department of Psychiatry, Command Hospital (Southern Command), Pune, Maharashtra, India
2 Department of Anaesthesia, AFMC, Pune, Maharashtra, India

Correspondence Address:
Dr. Amresh Dubey
Department of Psychiatry, Command Hospital, Pune, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ipj.ipj_118_20

Rights and Permissions

Alcohol withdrawal delirium (delirium tremens [DT]) is a medical emergency. Gamma-aminobutyric acid type A agonists (benzodiazepines [BZDs]) are the mainstay of treatment. Resistant alcohol withdrawal requires adjunctive medications along with BZDs and supportive care. DT is associated with significant autonomic dysfunction (sympathetic hyperactivity). Dexmedetomidine is a selective a2-adrenergic receptor agonist which reduces sympathetic over-activity and agitation in delirious patients. We present a case of alcohol withdrawal delirium (DT) who responded well to adjunctive dexmedetomidine infusion resulting in reduced sympathetic activity and reduced dose requirement of BZDs.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed93    
    Printed7    
    Emailed0    
    PDF Downloaded19    
    Comments [Add]    

Recommend this journal